How to reduce the risk of residual shunt during percutaneous treatment of ventricular septal defects

Rev Esp Cardiol (Engl Ed). 2022 Mar;75(3):279. doi: 10.1016/j.rec.2021.10.009. Epub 2021 Nov 21.

[Article in English, Spanish]

Authors

Fanyan Luo¹, Haisong Bu²

Affiliations

¹ Department of Cardiothoracic Surgery, Xiangya Hospital, Central South University, Changsha, P. R. China.
² Department of Cardiothoracic Surgery, Xiangya Hospital, Central South University, Changsha, P. R. China. Electronic address: [email protected].

PMID: 34815199
DOI: 10.1016/j.rec.2021.10.009

No abstract available

Publication types

Letter

MeSH terms

Cardiac Catheterization
Follow-Up Studies
Heart Septal Defects, Ventricular* / surgery
Humans
Septal Occluder Device*
Treatment Outcome